Evidence map›Paper›PMID 40158355›Full record

ArticleInternational journal of surgery case reports2025

Inflammatory myofibroblastic tumor of the bladder treated with partial cystectomy: Case report.

Chale Yohannes Tegegne, Mekuanint Asfaw Yitayew, Chalachew Tenna Alemu, Samuel Fekadu Shiferaw, Admassu Melaku Mikru, Abdiqadir Omer Rabile

Abstract readCase Reports
In one paragraph

Article in International journal of surgery case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chale Yohannes TegegneAddis Ababa University, School of Medicine, Addis Ababa, Ethiopia. Electronic address: chale-gsr-3132-13@aau.edu.et.
Mekuanint Asfaw YitayewAddis Ababa University, School of Medicine, Addis Ababa, Ethiopia.
Chalachew Tenna AlemuAddis Ababa University, School of Medicine, Addis Ababa, Ethiopia.
Samuel Fekadu ShiferawAddis Ababa University, School of Medicine, Addis Ababa, Ethiopia.
Admassu Melaku MikruAddis Ababa University, School of Medicine, Addis Ababa, Ethiopia.
Abdiqadir Omer RabileAddis Ababa University, School of Medicine, Addis Ababa, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInflammatory myofibroblastic tumor (IMT) is a rare form of tumor which is composed of fibroblastic and myofibroblastic spindle cells, with an inflammatory infiltrate of lymphocytes, plasma cells, and eosinophils. IMT may arise from different organs, but it is infrequent in the urinary bladder and usually manifests as haematuria. CASE PRESENTATION: Here we report a 20 years old male patient with no previous history of trauma or surgery presented with gross hematuria and severe anaemia. Further workup with transurethral resection biopsy and immunohistochemistry are supportive of IMT and we did partial cystectomy. Follow up cystoscopy after 3 months showed normal bladder wall. CLINICAL DISCUSSION: An inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal tumor. It comprises differentiated myofibroblastic spindle cells with numerous plasma cells and/or lymphocyte infiltrate. According to the World Health Organisation (WHO) classification, IMT is a low grade or borderline mesenchymal tumor. The commonest site for IMT is the lung, but it rarely occur in the genitourinary tract. Hematuria is the commonest manifestation of bladder IMT. Transurethral resection of bladder tumor (TURBT) and partial cystectomy are treatment modalities.

conclusionIMT of the bladder is a rare tumor which manifests mainly with hematuria. Although TURBT is the standard treatment for IMT, partial cystectomy has lower recurrence rate.

Indexed as

BladderInflammatory myofibroblastic tumorPartial cystectomyTransurethral resection of bladder tumor

Identifiers

PMID40158355
PMCPMC11997357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.